Metabolites
Displaying compounds 12501 - 12525 of 16042 in total
| YMDB ID | Name CAS Number | IUPAC Name | Formula Weight | Structure |
|---|---|---|---|---|
| YMDB00811 | N-Formylanthranilic acid 3342-77-6 | 2-formamidobenzoic acid | C8H7NO3 165.1461 | |
| YMDB16301 | N-hexacosanoyl-C20-4-hydroxysphinganine | N-(1,3,4-trihydroxyicosan-2-yl)hexacosanamide | C46H93NO4 724.253 | |
| YMDB00964 | N-Hexacosanoylphytosphingosine | N-[(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]hexacosanamide | C44H89NO4 696.1818 | |
| YMDB00621 | N-hexacosanylsphinganine | N-[(2S,3R)-1,3-dihydroxyoctadecan-2-yl]hexacosanamide | C44H89NO3 680.1824 | |
| YMDB01759 | N-Hexanal 66-25-1 | hexanal | C6H12O 100.1589 | |
| YMDB16308 | N-icosanoylphytosphingosine | N-[(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]icosanimidic acid | C38H77NO4 612.037 | |
| YMDB16052 | N-isopentylacetamide | N-(3-methylbutyl)acetamide | C7H15NO 129.203 | |
| YMDB01568 | N-Phenylacetylglycine 500-98-1 | 2-(2-phenylacetamido)acetic acid | C10H11NO3 193.1992 | |
| YMDB16307 | N-stearoylphytosphingosine | N-[(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]octadecanimidic acid | C36H73NO4 583.983 | |
| YMDB00963 | N-Tetracosanoylphytosphingosine | N-[(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]tetracosanamide | C42H85NO4 668.1286 | |
| YMDB00619 | N-tetracosanoylsphinganine | N-[(2S,3R)-1,3-dihydroxyoctadecan-2-yl]tetracosanamide | C42H85NO3 652.1292 | |
| YMDB01396 | N,N-dimethylformamide 68-12-2 | N,N-dimethylformamide | C3H7NO 73.0938 | |
| YMDB00940 | N,N'-diacetylchitobiosyldiphosphodolichol | {[(2R,3R,4R,5S,6R)-3-acetamido-5-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}({[hydroxy({[(6E,10E,14E,18E,22Z,26E,30E,34E,38E,42E,46E,50E,54E,58Z,62E,66E,70E,74E)-3,7,11,15,19,23,27,31,35,39,43,47,51,55,59,63,67,71,75,79-icosamethyloctaconta-6,10,14,18,22,26,30,34,38,42,46,50,54,58,62,66,70,74,78-nonadecaen-1-yl]oxy})phosphoryl]oxy})phosphinic acid | C116H192N2O17P2 1948.7164 | |
| YMDB00739 | N,N'-Diformyldityrosine | 3-{3-[5-(2-carboxy-2-formamidoethyl)-2-hydroxyphenyl]-4-hydroxyphenyl}-2-formamidopropanoic acid | C20H20N2O8 416.3814 | |
| YMDB00234 | N'-Formylkynurenine 1022-31-7 | 2-amino-4-(2-formamidophenyl)-4-oxobutanoic acid | C11H12N2O4 236.224 | |
| YMDB00760 | N(1)-(5-phospho-D-ribosyl)glycinamide 10074-18-7 | {[(2R,3S,4R)-5-(2-aminoacetamido)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid | C7H15N2O8P 286.1764 | |
| YMDB00759 | N(2)-formyl-N(1)-(5-phospho-D-ribosyl)glycinamide 349-34-8 | {[(2R,3S,4R)-3,4-dihydroxy-5-(2-formamidoacetamido)oxolan-2-yl]methoxy}phosphonic acid | C8H15N2O9P 314.1865 | |
| YMDB00703 | N(pros)-methyl-L-histidine 368-16-1 | (2S)-2-amino-3-(1-methyl-1H-imidazol-5-yl)propanoic acid | C7H11N3O2 169.1811 | |
| YMDB16281 | N1-(5-phospho-β-D-ribosyl)glycinamide | [5-(2-azaniumylacetamido)-3,4-dihydroxyoxolan-2-yl]methyl phosphate | C7H14N2O8P 285.169 | |
| YMDB00366 | N1-Acetylspermidine 14278-49-0 | N-{3-[(4-aminobutyl)amino]propyl}acetamide | C9H21N3O 187.2825 | |
| YMDB00339 | N1-Acetylspermine 25593-72-0 | N-[3-({4-[(3-aminopropyl)amino]butyl}amino)propyl]acetamide | C12H28N4O 244.3769 | |
| YMDB00080 | N10-Formyl-THF 2800-34-2 | (2S)-2-[(4-{N-[(4-hydroxy-2-imino-1,2,5,6,7,8-hexahydropteridin-6-yl)methyl]formamido}phenyl)formamido]pentanedioic acid | C20H23N7O7 473.4393 | |
| YMDB16237 | N5-Carboxyaminoimidazole ribonucleotide | (1-{3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl}-1H-imidazol-5-yl)carbamic acid | C9H14N3O9P 339.1959 | |
| YMDB00298 | N5-Formyl-THF 58-05-9 | 2-[(4-{[(2-amino-5-formyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid | C20H23N7O7 473.4393 | |
| YMDB00871 | N6-(1,2-Dicarboxyethyl)-AMP 19046-78-7 | (2S)-2-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-9H-purin-6-yl}amino)butanedioic acid | C14H18N5O11P 463.2934 |